Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment.
Rheumatol Int
; 32(12): 4061-3, 2012 Dec.
Article
en En
| MEDLINE
| ID: mdl-21922339
ABSTRACT
A patient with chronic inflammatory demyelinating polyradiculoneuropathy and systemic lupus erythematosus arising after rubella vaccination was initially treated with plasmapheresis, corticosteroids and intravenous immunoglobulins, with partial response. After shift to rituximab, most clinical symptoms improved markedly, emphasizing the possible role of this monoclonal antibody in conventional therapy-resistant cases.
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Antirreumáticos
/
Polirradiculoneuropatía Crónica Inflamatoria Desmielinizante
/
Anticuerpos Monoclonales de Origen Murino
/
Lupus Eritematoso Sistémico
Límite:
Adult
/
Female
/
Humans
Idioma:
En
Revista:
Rheumatol Int
Año:
2012
Tipo del documento:
Article
País de afiliación:
Argentina